Identify microRNAs in Cachexia in Pancreatic Carcinoma

Stopped early

Conditions studied: Resectable Pancreatic Adenocarcinoma

In brief

The purpose of this study is to determine the proportion of pancreatic patients who experience weight loss and cachexia, and to identify any differences in the genes between patient groups.

Key facts

Study ID

NCT05275075

Run by

University of Oklahoma

People needed

40

Starts

2022-12-07

Expected to finish

2026-04-03

Last updated by the study team

2026-06-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female patient, who is ≥ 18 years old at the time of informed consent.
• Patients with operable pancreatic tumors diagnosed in the last 12 months prior to consent with clinical discretion or pathology confirmed as adenocarcinoma.
• Patient has stage I or higher disease who is considered a candidate for surgical resection of pancreatic cancer, with or without neoadjuvant chemotherapy.
• Ability to provide written informed consent and HIPAA authorization.

You may not qualify if…

• Patients with pancreatic adenocarcinoma who do not meet the criteria for surgical resection.
• Patient has cancer diagnosis other than primary pancreatic adenocarcinoma.

Where it is running

• Stephenson Cancer Center — Oklahoma City, Oklahoma, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.